Acute Porphyria Drug Database

Monograph

G02CX01 - Atosiban
Propably not porphyrinogenic
PNP

Rationale
Synthetic oxytocine peptide.
Chemical description
Synthetic peptide (oxytocine) given i.v. to delay deliveriy.Administered according a three-step formulae for 45 hours, in a total not more than 330 mg. Two metabolites identified.

Similar drugs
Explore alternative drugs in similar therapeutic classes G02C / G02CX or go back.

Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia). Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway). What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors. We strive to improve it continuously.
Netherlands
Atosiban · Atosiban Accord 37,5 mg/5 ml concentraat voor oplossing voor infusie · Atosiban Accord 6,75 mg/0,9 ml oplossing voor injectie in een voorgevulde spuit · Atosiban Ever Pharma 37,5 mg/5 ml concentraat voor oplossing voor infusie · Atosiban Ever Pharma 6,75 mg/0,9 ml oplossing voor injectie · Atosiban Ever Pharma 75 mg/10 ml concentraat voor oplossing voor infusie · Atosiban SUN 37.5 mg/5 ml concentraat voor oplossing voor infusie · Atosiban SUN 6.75 mg/0.9 ml oplossing voor injectie · Tractocile · Tractocile 6,75 mg/ 0,9 ml oplossing voor injectie · Tractocile 37,5 mg/ 5 ml concentraat voor oplossing voor infusie
Belgium
Atosiban · Atosiban Altan 37.5 mg/5 ml sol. inj. (à diluer) i.v. flac. · Atosiban Altan 6.75 mg/0.9 ml sol. inj. i.v. amp. · Atosiban Ever Pharma 37.5 mg/5 ml sol. perf. (à diluer) i.v. · Atosiban Ever Pharma 6.75 mg/0.9 ml sol. inj. i.v. · Atosiban Ever Pharma 75 mg/10 ml sol. perf. (à diluer) i.v. · Atosiban Sun 37.5 mg/5 ml sol. perf. (à diluer) i.v. flac. · Atosiban Sun 6.75 mg/0.9 ml sol. inj. i.v. flac. · Tractocile · Tractocile 37.5 mg/5 ml sol. perf. (à diluer) i.v. flac. · Tractocile 6.75 mg/0.9 ml sol. inj. i.v. flac.
United Kingdom
Atosiban · Atosiban 37.5mg/5ml concentrate for solution for infusion vials · Atosiban 37.5mg/5ml solution for infusion vials · Atosiban 6.75mg/0.9ml solution for injection ampoules · Atosiban 6.75mg/0.9ml solution for injection pre-filled syringes · Atosiban 6.75mg/0.9ml solution for injection vials · Tractocile · Tractocile 37.5mg/5ml solution for infusion vials · Tractocile 6.75mg/0.9ml solution for injection vials
Denmark
Atosiban · Atosiban "Accord" · Atosiban "EVER Pharma" · Atosiban "SUN" · Tractocile
Norway
Atosiban Accord · Atosiban SUN · Tractocile
Poland
Atosiban Accord · Atosiban EVER Pharma · Atosiban Mercapharm · Atosiban SUN · Tractocile
Luxembourg
TRACTOCILE
Iceland
Atosiban · Atosiban SUN · Tractocile
Finland
Atosiban · Atosiban Accord · Atosiban Ever Pharma · Atosiban Sun · Tractocile
Latvia
Atosiban · Atosiban PharmIdea · Atosiban SUN · Tractocile
Serbia
Tractocile · Tractocile®
 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙